Impact studies: mathematical models

A number of studies have attempted to quantify the possible impact of PrEP under a number of different efficacy, usage and behavioural scenarios. A 2007 study presented in PLoS One journal found that PrEP could prevent up to three million new HIV infections over ten years in southern Africa if used consistently, according to mathematical modelling.1

Epidemiologists set out to model the effects of PrEP under different scenarios in Africa, varying the efficacy of PrEP and the effects of sexual disinhibition within the population after its introduction in order to illustrate the range of effects that might be expected.

The model looked at the effect of introducing PrEP in epidemics where adult HIV prevalence has reached 20%.

There were three scenarios within the model:

  • An optimistic scenario in which PrEP was assumed to be effective 90% of the time and used by 75% of the sexually active population. In this case, there was a significant public health benefit with a reduction of new HIV infections by 74%.
  • A neutral scenario in which PrEP was effective 60% of the time and used by 50% of the sexually active population. This gave a 25% reduction in infections.
  • A pessimistic scenario in which PrEP was effective 30% of the time and used by 25% of the sexually active population.  A 3.3% reduction was found.

The researchers also looked at the cost-benefit of distributing PrEP and found that targeting it to individuals who were the most sexually active produced a significant decline in infections at a much lower cost than if PrEP were distributed to the general population.

To address the issue of sexual disinhibition, the researchers assumed a 100% increase in risky sexual behaviour and observed that there was still a notable reduction of HIV infections in the range of 23.4% to 62.7%.

At the 2010 Microbicides conference, a couple of presentations modelled the impact of either a microbicide or PrEP, and Marie-Claude Boily of Imperial College introduced a meta-review of a number of the mathematical models of these approaches.2

These models show that the effect on HIV incidence and prevalence of microbicides and PrEP could vary enormously, according to local conditions. In some cases their adoption could cause an increase in HIV infections. Boily said that models predict some paradoxical effects.

PrEP might have much more effect in a low-prevalence area than a high-prevalence one, and it might reduce HIV infections in people who don’t often use condoms, while considerably increasing infections in people who were using them consistently before the introduction of PrEP.

If PrEP or microbicide adoption were to result in anything more than a slight drop in condom use, the result could be an increase in HIV cases; and even a small amount of anal sex in a heterosexual population may slash the effectiveness of a vaginal microbicide.

Boily presented several different scenarios that modelled condom substitution, all assuming the introduction of a prevention method of 50% efficacy, used 50% of the time.

Situations of initially high condom use were much more sensitive to condom substitution: if condom use was initially 90%, it would only take a 2% drop in use for infections to start rising, despite the introduction of a microbicide. Audience members commented that this validated the fears of groups representing female sex workers, who have managed to enforce this level of condom use in clients. If microbicide use led men to demand more sex without condoms, then both worker and client would be more at risk.

Tell us why you visited aidsmap today

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?


Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email


  1. Abbas UL et al. Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS One 9: e875, 2007
  2. Boily M-C Population-level impact of microbicides to prevent HIV: the efficacy that matters? International Microbicides Conference, Pittsburgh, symposium presentation 176, 2010

Impact studies: mathematical models

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.